Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Arcutis Biotherapeutics, Inc.ARQT · Entity 4236 | Director | June 05, 2026 | June 10, 2026 |
| INTUITIVE SURGICAL INCISRG · Entity 2878 | Director | April 30, 2026 | May 01, 2026 |
| Sienna Biopharmaceuticals, Inc.SNNA · Entity 154554 | Director | May 30, 2019 | June 03, 2019 |
| Unity Biotechnology, Inc.UBX · Entity 77428 | Director | June 21, 2024 | June 21, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Arcutis Biotherapeutics, Inc.
Report date June 05, 2026 · Filed June 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 27,901 |
Reported balance
After 2026-06-05 transaction · row 1
1 source rowRow 1 · 2026-06-05 · Grant · Acquired 5,778 · Balance 27,901 F1: Represents Restricted Stock Units ("RSUs") granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof, which shall occur on the earlier of the first anniversary of the grant date, June 5, 2026, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date. Upon vesting of the RSUs, the settlement has been deferred by the Reporting Person, pursuant to the terms of the RSU Deferral Election Form adopted on October 28, 2025, maintained by the Company. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $21.23 · Expires 2036-06-05 | Direct | 16,667 |
Reported balance
After 2026-06-05 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-06-05 · Grant · Acquired 16,667 · Balance 16,667 F3: The underlying shares subject to the option vest and become exercisable as to 100% on the earlier of the first anniversary of the grant date, June 5, 2026, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date. |
| Common StockSEC Table I · non-derivative | IndirectBy Leonard Family Trust dated August 28, 1996 | 1,750 |
Reported balance
Holding disclosure · report date 2026-06-05 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,750 F2: Shares held by Leonard Family Trust dated August 28, 1996, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents Restricted Stock Units ("RSUs") granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof, which shall occur on the earlier of the first anniversary of the grant date, June 5, 2026, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date. Upon vesting of the RSUs, the settlement has been deferred by the Reporting Person, pursuant to the terms of the RSU Deferral Election Form adopted on October 28, 2025, maintained by the Company.
F2: Shares held by Leonard Family Trust dated August 28, 1996, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.
F3: The underlying shares subject to the option vest and become exercisable as to 100% on the earlier of the first anniversary of the grant date, June 5, 2026, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date.
INTUITIVE SURGICAL INC
Report date April 30, 2026 · Filed May 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 901 |
Reported balance
After 2026-04-30 transaction · row 1
1 source rowRow 1 · 2026-04-30 · Exercise / conversion · Acquired 531 · Balance 901 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-04-30 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-04-30 · Exercise / conversion · Disposed 531 · Balance 0 F1: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service. |
| Restricted Stock Units - 4-30-2026SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 554 |
Reported balance
After 2026-04-30 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-04-30 · Grant · Acquired 554 · Balance 554 F1: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service. |
Filing footnotes · ownership attribution and instrument terms
F1: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service.
Sienna Biopharmaceuticals, Inc.
Report date May 30, 2019 · Filed June 03, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Options (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.22 · Expires 2029-05-30 | Direct | 25,000 |
Reported balance
After 2019-05-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-05-30 · Grant · Acquired 25,000 · Balance 25,000 F1: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, subject to continued service through each applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, subject to continued service through each applicable vesting date.
Unity Biotechnology, Inc.
Report date June 21, 2024 · Filed June 21, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.38 · Expires 2034-06-20 | Direct | 10,000 |
Reported balance
After 2024-06-21 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-06-21 · Grant · Acquired 10,000 · Balance 10,000 F1: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the one-year anniversary measured from June 21, 2024 or (ii) the date of the 2025 Annual Meeting of the Issuer's stockholders, assuming continuous service as a Director until such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the one-year anniversary measured from June 21, 2024 or (ii) the date of the 2025 Annual Meeting of the Issuer's stockholders, assuming continuous service as a Director until such vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 05, 2026 Filed Jun 10, 2026 01:21 UTC | Arcutis Biotherapeutics, Inc. ARQT · Entity 4236 | GrantStock Option (right to buy) · Derivative | 16,667 | $0.00 Strike: $21.23 | $0.00 |
DisclosureSEC source: 0001628280-26-042043 · wk-form4_1781054471.xml · derivative · entry 3 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,667 Underlying: Common Stock · 16,667 shares Expires 2036-06-05 F3 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% on the earlier of the first anniversary of the grant date, June 5, 2026, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date. Read SEC document |
| June 05, 2026 Filed Jun 10, 2026 01:21 UTC | Arcutis Biotherapeutics, Inc. ARQT · Entity 4236 | GrantCommon Stock | 5,778 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-042043 · wk-form4_1781054471.xml · nonDerivative · entry 1 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,901 F1 · shares: Represents Restricted Stock Units ("RSUs") granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof, which shall occur on the earlier of the first anniversary of the grant date, June 5, 2026, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date. Upon vesting of the RSUs, the settlement has been deferred by the Reporting Person, pursuant to the terms of the RSU Deferral Election Form adopted on October 28, 2025, maintained by the Company. Read SEC document |
| April 30, 2026 Filed May 1, 2026 01:02 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | GrantRestricted Stock Units - 4-30-2026 · Derivative | 554 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001416180-26-000004 · edgardoc.xml · derivative · entry 3 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 554 Underlying: Common Stock · 554 shares Expires not disclosed F1 · derivative.exercise_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service. F1 · derivative.expiration_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service. Read SEC document |
| April 30, 2026 Filed May 1, 2026 01:02 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionRestricted Stock Units · Derivative | 531 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001416180-26-000004 · edgardoc.xml · derivative · entry 2 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 531 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service. F1 · derivative.expiration_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service. Read SEC document |
| April 30, 2026 Filed May 1, 2026 01:02 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 531 | $0.00 | $0.00 |
DisclosureSEC source: 0001416180-26-000004 · edgardoc.xml · nonDerivative · entry 1 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 901 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:17 UTC | Arcutis Biotherapeutics, Inc. ARQT · Entity 4236 | Exercise / conversionStock Option (right to buy) · Derivative | 12,220 | $0.00 Strike: $7.51 | $0.00 |
DisclosureSEC source: 0001628280-26-014642 · wk-form4_1772659056.xml · derivative · entry 6 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,220 shares Expires 2033-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on November 18, 2025, by the Reporting Person, with a plan end date of February 16, 2027. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:17 UTC | Arcutis Biotherapeutics, Inc. ARQT · Entity 4236 | Exercise / conversionStock Option (right to buy) · Derivative | 27,052 | $0.00 Strike: $8.63 | $0.00 |
DisclosureSEC source: 0001628280-26-014642 · wk-form4_1772659056.xml · derivative · entry 5 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 27,052 shares Expires 2034-06-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on November 18, 2025, by the Reporting Person, with a plan end date of February 16, 2027. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:17 UTC | Arcutis Biotherapeutics, Inc. ARQT · Entity 4236 | SaleCommon Stock | 39,272 | $25.39 | $997,194.62 |
DisclosureSEC source: 0001628280-26-014642 · wk-form4_1772659056.xml · nonDerivative · entry 3 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,123 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on November 18, 2025, by the Reporting Person, with a plan end date of February 16, 2027. F2 · price: The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $25.05 to $26.039, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:17 UTC | Arcutis Biotherapeutics, Inc. ARQT · Entity 4236 | Exercise / conversionCommon Stock | 12,220 | $7.51 | $91,772.20 |
DisclosureSEC source: 0001628280-26-014642 · wk-form4_1772659056.xml · nonDerivative · entry 2 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 61,395 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on November 18, 2025, by the Reporting Person, with a plan end date of February 16, 2027. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:17 UTC | Arcutis Biotherapeutics, Inc. ARQT · Entity 4236 | Exercise / conversionCommon Stock | 27,052 | $8.63 | $233,458.76 |
DisclosureSEC source: 0001628280-26-014642 · wk-form4_1772659056.xml · nonDerivative · entry 1 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 49,175 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on November 18, 2025, by the Reporting Person, with a plan end date of February 16, 2027. Read SEC document |
| January 29, 2026 Filed Jan 31, 2026 02:45 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | OtherCommon Stock | 369 | $0.00 | $0.00 |
DisclosureSEC source: 0001416180-26-000002 · edgardoc.xml · nonDerivative · entry 1 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 370 F1 · kind: Transfer of shares pursuant to divorce decree. Read SEC document |
| November 13, 2025 Filed Nov 17, 2025 21:39 UTC | Arcutis Biotherapeutics, Inc. ARQT · Entity 4236 | GiftCommon Stock | 4,312 | $0.00 | $0.00 |
DisclosureSEC source: 0001416180-25-000009 · wk-form4_1763415543.xml · nonDerivative · entry 1 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,123 F1 · kind: The Reporting Person gifted shares to a Charitable Remainder Unitrust. Read SEC document |
| November 12, 2025 Filed Nov 13, 2025 18:35 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | GiftCommon Stock | 1,606 | $0.00 | $0.00 |
DisclosureSEC source: 0001416180-25-000007 · edgardoc.xml · nonDerivative · entry 1 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 739 F1 · kind: The filer gifted shares to a CRUT. Read SEC document |
| June 12, 2025 Filed Jun 17, 2025 00:17 UTC | Arcutis Biotherapeutics, Inc. ARQT · Entity 4236 | GrantStock Option (right to buy) · Derivative | 20,568 | $0.00 Strike: $13.50 | $0.00 |
DisclosureSEC source: 0002065881-25-000026 · wk-form4_1750119450.xml · derivative · entry 3 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,568 Underlying: Common Stock · 20,568 shares Expires 2035-06-12 F3 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% on the earlier of the first anniversary of the grant date, June 12, 2025, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date. Read SEC document |
| June 12, 2025 Filed Jun 17, 2025 00:17 UTC | Arcutis Biotherapeutics, Inc. ARQT · Entity 4236 | GrantCommon Stock | 7,609 | $0.00 | $0.00 |
DisclosureSEC source: 0002065881-25-000026 · wk-form4_1750119450.xml · nonDerivative · entry 1 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,435 F1 · shares: Represents Restricted Stock Units ("RSUs") granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof, which shall occur on the earlier of the first anniversary of the grant date, June 12, 2025, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date. Upon vesting of the RSUs, the settlement has been deferred by the Reporting Person, pursuant to the terms of the RSU Deferral Election Form adopted on October 23, 2024, maintained by the Company. Read SEC document |
| May 01, 2025 Filed May 2, 2025 01:06 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | GrantRestricted Stock Units · Derivative | 531 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001035267-25-000149 · edgardoc.xml · derivative · entry 1 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 531 Underlying: Common Stock · 531 shares Expires not disclosed F1 · derivative.exercise_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service. F1 · derivative.expiration_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service. Read SEC document |
| April 25, 2025 Filed Apr 25, 2025 18:01 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionRestricted Stock Units · Derivative | 739 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001035267-25-000115 · edgardoc.xml · derivative · entry 2 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 739 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service. F1 · derivative.expiration_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service. Read SEC document |
| April 25, 2025 Filed Apr 25, 2025 18:01 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 739 | $0.00 | $0.00 |
DisclosureSEC source: 0001035267-25-000115 · edgardoc.xml · nonDerivative · entry 1 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,345 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 21, 2024 Filed Jun 21, 2024 16:30 UTC | Unity Biotechnology, Inc. UBX · Entity 77428 | GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $1.38 | $0.00 |
DisclosureSEC source: 0000950170-24-076282 · ownership.xml · derivative · entry 1 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2034-06-20 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the one-year anniversary measured from June 21, 2024 or (ii) the date of the 2025 Annual Meeting of the Issuer's stockholders, assuming continuous service as a Director until such vesting date. Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 20:52 UTC | Arcutis Biotherapeutics, Inc. ARQT · Entity 4236 | GrantStock Option (right to buy) · Derivative | 27,052 | $0.00 Strike: $8.63 | $0.00 |
DisclosureSEC source: 0001787306-24-000106 · wk-form4_1718743948.xml · derivative · entry 3 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,052 Underlying: Common Stock · 27,052 shares Expires 2034-06-14 F3 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of June 14, 2024, subject to the non-employee director's continuous service. Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 20:52 UTC | Arcutis Biotherapeutics, Inc. ARQT · Entity 4236 | GrantCommon Stock | 10,139 | $0.00 | $0.00 |
DisclosureSEC source: 0001787306-24-000106 · wk-form4_1718743948.xml · nonDerivative · entry 1 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,826 F1 · shares: Represents Restricted Stock Units {"RSUs") granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. Read SEC document |
| April 25, 2024 Filed Apr 26, 2024 19:44 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionRestricted Stock Units · Derivative | 569 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001035267-24-000153 · edgardoc.xml · derivative · entry 2 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 569 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service. F1 · derivative.expiration_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service. Read SEC document |
| April 25, 2024 Filed Apr 26, 2024 19:44 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 569 | $0.00 | $0.00 |
DisclosureSEC source: 0001035267-24-000153 · edgardoc.xml · nonDerivative · entry 1 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,606 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 25, 2024 Filed Apr 27, 2024 00:21 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | GrantRestricted Stock Units · Derivative | 739 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001035267-24-000161 · edgardoc.xml · derivative · entry 1 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 739 Underlying: Common Stock · 739 shares Expires not disclosed F1 · derivative.exercise_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service. F1 · derivative.expiration_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service. Read SEC document |
| February 15, 2024 Filed Feb 15, 2024 20:38 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | GiftCommon Stock | 2,547 | $0.00 | $0.00 |
DisclosureSEC source: 0001035267-24-000050 · edgardoc.xml · nonDerivative · entry 1 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,037 F1 · kind: The filer gifted 2,547 shares to a CRUT. Read SEC document |
| June 23, 2023 Filed Jun 26, 2023 17:03 UTC | Unity Biotechnology, Inc. UBX · Entity 77428 | GrantStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $3.25 | $0.00 |
DisclosureSEC source: 0000899243-23-016496 · doc4.xml · derivative · entry 1 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires 2033-06-22 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the one-year anniversary measured from June 23, 2023 or (ii) the date of the 2024 Annual Meeting of the Issuer's stockholders, assuming continuous service as a Director until such vesting date. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 23:02 UTC | Arcutis Biotherapeutics, Inc. ARQT · Entity 4236 | GrantStock Option (right to buy) · Derivative | 12,220 | $0.00 Strike: $7.51 | $0.00 |
DisclosureSEC source: 0001787306-23-000054 · wk-form4_1685746945.xml · derivative · entry 3 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,220 Underlying: Common Stock · 12,220 shares Expires 2033-05-31 F3 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of May 31, 2023. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 23:02 UTC | Arcutis Biotherapeutics, Inc. ARQT · Entity 4236 | GrantCommon Stock | 4,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001787306-23-000054 · wk-form4_1685746945.xml · nonDerivative · entry 1 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,687 F1 · balance_after: Includes 4,375 Restricted Stock Units (?RSUs?). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| April 27, 2023 Filed Apr 28, 2023 22:57 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | GrantRestricted Stock Units · Derivative | 569 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001035267-23-000118 · edgardoc.xml · derivative · entry 4 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 569 Underlying: Common Stock · 569 shares Expires not disclosed F2 · derivative.exercise_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service. F2 · derivative.expiration_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service. Read SEC document |
| April 27, 2023 Filed Apr 28, 2023 22:57 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionRestricted Stock Units · Derivative | 482 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001035267-23-000118 · edgardoc.xml · derivative · entry 3 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 482 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service. F2 · derivative.expiration_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service. Read SEC document |
| April 27, 2023 Filed Apr 28, 2023 22:57 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 1,709 | $0.00 Strike: $295.92 | $0.00 |
DisclosureSEC source: 0001035267-23-000118 · edgardoc.xml · derivative · entry 2 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,709 Underlying: Common Stock · 1,709 shares Expires 2030-04-26 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service as a director to the issuer. Read SEC document |
| April 27, 2023 Filed Apr 28, 2023 22:57 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 482 | $0.00 | $0.00 |
DisclosureSEC source: 0001035267-23-000118 · edgardoc.xml · nonDerivative · entry 1 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,584 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 24, 2022 Filed Jun 27, 2022 17:52 UTC | Unity Biotechnology, Inc. UBX · Entity 77428 | GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $0.59 | $0.00 |
DisclosureSEC source: 0000899243-22-024220 · doc4.xml · derivative · entry 1 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2032-06-23 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the one-year anniversary measured from June 24, 2022 or (ii) the date of the 2023 Annual Meeting of the Issuer's stockholders, assuming continuous service as a Director until such vesting date. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 20:52 UTC | Arcutis Biotherapeutics, Inc. ARQT · Entity 4236 | GrantStock Option (Right to Buy) · Derivative | 11,796 | $0.00 Strike: $20.29 | $0.00 |
DisclosureSEC source: 0001567619-22-012311 · doc1.xml · derivative · entry 3 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,796 Underlying: Common Stock · 11,796 shares Expires 2032-06-01 F3 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of June 1, 2022. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 20:52 UTC | Arcutis Biotherapeutics, Inc. ARQT · Entity 4236 | GrantCommon Stock | 4,312 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-012311 · doc1.xml · nonDerivative · entry 1 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,312 F1 · balance_after: Includes 4,312 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| April 28, 2022 Filed May 2, 2022 15:33 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | GrantRestricted Stock Units · Derivative | 482 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001035267-22-000110 · edgardoc.xml · derivative · entry 2 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 482 Underlying: Common Stock · 482 shares Expires not disclosed F2 · derivative.exercise_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service. F2 · derivative.expiration_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service. Read SEC document |
| April 28, 2022 Filed May 2, 2022 15:33 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 1,448 | $0.00 Strike: $243.26 | $0.00 |
DisclosureSEC source: 0001035267-22-000110 · edgardoc.xml · derivative · entry 1 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,448 Underlying: Common Stock · 1,448 shares Expires 2029-04-27 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service as a director to the issuer. Read SEC document |
| April 22, 2022 Filed Apr 26, 2022 16:42 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionRestricted Stock Units · Derivative | 555 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-008949 · doc1.xml · derivative · entry 2 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 555 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of the Stockholders, subject to the Reporting Person's continued service. F2 · derivative.expiration_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of the Stockholders, subject to the Reporting Person's continued service. F1 · balance_after: On October 5, 2021, the common stock equity grants of Intuitive Surgical split 3-for-1, resulting in the Reporting Person's ownership of the company's stock and equity grants to increase (for every one share owned or granted, 2 additional shares were issued) and the exercise price of stock grants to decrease to 1/3rd of the original grant price. Read SEC document |
| April 22, 2022 Filed Apr 26, 2022 16:42 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 555 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-008949 · doc1.xml · nonDerivative · entry 1 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,102 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: On October 5, 2021, the common stock equity grants of Intuitive Surgical split 3-for-1, resulting in the Reporting Person's ownership of the company's stock and equity grants to increase (for every one share owned or granted, 2 additional shares were issued) and the exercise price of stock grants to decrease to 1/3rd of the original grant price. Read SEC document |
| September 02, 2021 Filed Sep 7, 2021 23:53 UTC | Arcutis Biotherapeutics, Inc. ARQT · Entity 4236 | GrantStock Option (Right to Buy) · Derivative | 32,907 | $0.00 Strike: $22.16 | $0.00 |
DisclosureSEC source: 0001567619-21-016829 · doc1.xml · derivative · entry 1 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,907 Underlying: Common Stock · 32,907 shares Expires 2031-09-02 F1 · derivative.exercise_date: The option vests as to 1/3rd of the total shares on each of September 2, 2022, September 2, 2023 and September 2, 2024, subject to Reporting Person's continuous service to the Issuer on each such vesting date. Read SEC document |
| August 03, 2021 Filed Aug 3, 2021 23:39 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 996 | $0.00 Strike: $462.71 | $0.00 |
DisclosureSEC source: 0001035267-21-000135 · edgardoc.xml · derivative · entry 3 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 996 shares Expires 2028-04-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were exercised and sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 2, 2021. F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant or at the next Shareholders Meeting, whichever should take place first, provided that vesting will cease on termination of the Directors service to the Company. Read SEC document |
| August 03, 2021 Filed Aug 3, 2021 23:39 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 996 | $1,000.00 | $996,000.00 |
DisclosureSEC source: 0001035267-21-000135 · edgardoc.xml · nonDerivative · entry 2 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 849 F1 · kind: These shares were exercised and sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 2, 2021. Read SEC document |
| August 03, 2021 Filed Aug 3, 2021 23:39 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 996 | $462.71 | $460,859.16 |
DisclosureSEC source: 0001035267-21-000135 · edgardoc.xml · nonDerivative · entry 1 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,845 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were exercised and sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 2, 2021. Read SEC document |
| June 24, 2021 Filed Jun 28, 2021 17:16 UTC | Unity Biotechnology, Inc. UBX · Entity 77428 | GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $4.18 | $0.00 |
DisclosureSEC source: 0000899243-21-026229 · doc4.xml · derivative · entry 1 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2031-06-23 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the one-year anniversary measured from June 24, 2021 or (ii) the date of the 2022 Annual Meeting of the Issuer's stockholders, assuming continuous service as a Director until such vesting date. Read SEC document |
| April 22, 2021 Filed Apr 26, 2021 19:05 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | GrantRestricted Stock Units · Derivative | 185 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001035267-21-000087 · edgardoc.xml · derivative · entry 4 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185 Underlying: Common Stock · 185 shares Expires not disclosed F2 · derivative.exercise_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service. F2 · derivative.expiration_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service. Read SEC document |
| April 22, 2021 Filed Apr 26, 2021 19:05 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionRestricted Stock Units · Derivative | 255 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001035267-21-000087 · edgardoc.xml · derivative · entry 3 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 255 shares Expires 2021-04-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service. Read SEC document |
| April 22, 2021 Filed Apr 26, 2021 19:05 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 557 | $0.00 Strike: $859.66 | $0.00 |
DisclosureSEC source: 0001035267-21-000087 · edgardoc.xml · derivative · entry 2 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 557 Underlying: Common Stock · 557 shares Expires 2031-04-22 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service as a director to the issuer. Read SEC document |
| April 22, 2021 Filed Apr 26, 2021 19:05 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 255 | $0.00 | $0.00 |
DisclosureSEC source: 0001035267-21-000087 · edgardoc.xml · nonDerivative · entry 1 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 849 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 30, 2020 Filed Feb 2, 2021 17:25 UTC | Unity Biotechnology, Inc. UBX · Entity 77428 | GiftCommon Stock, $0.0001 par value | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-004231 · doc5.xml · nonDerivative · entry 1 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 F1 · ownership.nature: The shares were held by Keith Richard Leonard, Jr. 2019 Retained Annuity Trust dated 16 Dec 2019. Read SEC document |
| June 22, 2020 Filed Jun 24, 2020 16:58 UTC | Unity Biotechnology, Inc. UBX · Entity 77428 | Tax withholdingCommon Stock, $0.0001 par value | 4,711 | $9.67 | $45,555.37 |
DisclosureSEC source: 0000899243-20-017552 · doc4.xml · nonDerivative · entry 1 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,546 F1 · kind: The shares were withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the release of shares subject to vesting. F2 · balance_after: Includes Restricted Stock Units which vest over time measured from the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.